We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A New Jersey judge has refused to dismiss counterclaims asserted by Navinta against Abraxis Bioscience in a patent case involving the anesthesia Naropin.